Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis.

MLA

Gottlieb, A., et al. “Effects of Administration of a Single Dose of a Humanized Monoclonal Antibody to CD11a on the Immunobiology and Clinical Activity of Psoriasis.” Journal of the American Academy of Dermatology, vol. 42, no. 3, Mar. 2000, pp. 428–35. EBSCOhost, https://doi.org/10.1016/s0190-9622(00)90214-7.

APA

Gottlieb, A., Krueger, J. G., Bright, R., Ling, M., Lebwohl, M., Kang, S., Feldman, S., Spellman, M., Wittkowski, K., Ochs, H. D., Jardieu, P., Bauer, R., White, M., Dedrick, R., & Garovoy, M. (2000). Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis. Journal of the American Academy of Dermatology, 42(3), 428–435. https://doi.org/10.1016/s0190-9622(00)90214-7

Chicago

Gottlieb, A, J G Krueger, R Bright, M Ling, M Lebwohl, S Kang, S Feldman, et al. 2000. “Effects of Administration of a Single Dose of a Humanized Monoclonal Antibody to CD11a on the Immunobiology and Clinical Activity of Psoriasis.” Journal of the American Academy of Dermatology 42 (3): 428–35. doi:10.1016/s0190-9622(00)90214-7.